VAIAF yields 1.44% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, VAIAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VAIAF + PFE for your $10,000?
Vaisala Oyj engages in the weather and environmental, and industrial measurement business serving weather related and industrial markets. The company's products include industrial measurement systems, such as HVAC and indoor air meters, industrial transmitters, power transformer monitoring systems, probes and OEM modules, handheld meters, in-line process refractometers, biogas monitoring systems, liquid measurement systems, and viewLinc continuous monitoring systems. It also provides weather and environmental solutions, such as automatic weather stations, radiosondes and sounding systems, weather and environmental sensors, weather radars, wind lidars, visibility and present weather sensors, ceilometers, lightning sensors, air quality sensors, and road state sensors, as well as pressure, temperature, and humidity sensors; and operates an online store. In addition, the company offers maintenance, calibration and repair, and modernization services, as well as extended warranties and data-based solutions. Vaisala Oyj serves various industrial customers, including data centers, chemicals and allied products, fuel cells, power transformers, semiconductors, automotive, cleanrooms, HVAC and indoor air, warehouses, battery manufacturing, compressed air, life sciences and pharmaceutical, sugar, sweeteners, biogas, and research facilities and metrology; pulp, paper, and wood; food, beverages, and agriculture; and oil and gas refineries, and petrochemicals. It also serves weather-dependent markets mainly meteorology, ground transportation, aviation, maritime, renewable and wind energy, and urban weather and environment. The company has operations in Europe, the Middle East, Africa, North and South Americas, and the Asia Pacific. Vaisala Oyj was founded in 1936 and is headquartered in Vantaa, Finland.
Full VAIAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.